 |
May 5, 2022 - Puma Biotechnology Reports First Quarter 2022 Financial Results
Read
April 27, 2022 - Puma Biotechnology Announces Publication of Neratinib Abstract Titles for the 2022 ASCO Annual Meeting
Read
April 21, 2022 - Puma Biotechnology to Host Conference Call to Discuss First Quarter Financial Results
Read
Mar. 10, 2022 - Puma Biotechnology Announces $10 Million Private Placement
Read
Mar. 7, 2022 - Puma Biotechnology to Participate in Breast Cancer Panel at Cowen’s Annual Health Care Conference
Read
Mar. 3, 2022 - Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results
Read
Feb. 16, 2022 - Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results
Read
Jan. 12, 2022 - Puma Biotechnology’s NERLYNX® Included in Two Important NCCN Clinical Practice Guideline Updates for the Treatment of Breast Cancer
Read
Jan. 10, 2022 - Puma Biotechnology Releases Updated Corporate Presentation
Read
Jan. 4, 2022 - Puma Biotechnology to Present at the H.C. Wainwright BioConnect Conference
Read
Dec. 10, 2021 - Puma Biotechnology Presents Updates from the SUMMIT Trial at the 2021 SABCS Annual Meeting
Read | Slides
Nov. 23, 2021 - Puma Biotechnology Announces U.S Patent Term Extension for NERLYNX® (neratinib)
Read
Nov. 20, 2021 - Puma Biotechnology Presents Data from the Neratinib Arm of the INSIGhT Trial at the 2021 SNO Annual Meeting
Read
Nov. 19, 2021 - Puma Biotechnology to Present Neratinib Data at the San Antonio Breast Cancer Symposium (SABCS)
Read
Nov. 4, 2021 - Puma Biotechnology Reports Third Quarter 2021 Financial Results
Read
Oct. 21, 2021 - Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
Read
Sept. 21, 2021 - Puma Biotechnology to Present at the Cantor Virtual Global Healthcare Conference
Read
Sept. 7, 2021 - Puma Biotechnology to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Read
|
|
Upcoming Events
June 3 – 7, 2022 - ASCO 2022 Annual Meeting
More
Past Events
May 5, 2022 - Puma Biotechnology 1Q-2022 Financial Results Conference Call
More
March 9, 2022 - Cowen’s 42nd Annual Health Care Conference
More
March 3, 2022 - Puma Biotechnology Full Year 2021 Financial Results Conference Call
More
Jan. 10, 2022 - Puma Biotechnology Releases Updated Corporate Presentation
More
Jan. 10, 2022 - H.C. Wainwright BioConnect Conference
More
Dec. 7-10, 2021 - San Antonio Breast Cancer Symposium
More
Nov. 20, 2021 - Society for Neuro-Oncology Annual Meeting
More
Oct. 21, 2021 - Puma Biotechnology 3Q-2021 Financial Results Conference Call
More
Sept. 28, 2021 - Cantor Virtual Global Healthcare Conference
More
Sept. 13-15, 2021 - H.C. Wainwright 23rd Annual Global Investment Conference
More
|
Annual Report Archives
Puma Biotechnology, Inc.
10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024
424-248-6500 Main
424-248-6501 Fax
Medical Inquiries:
1-844-MED-PUMA (1-844-633-7862), or
medinfo@pumabiotechnology.com
Business Development:
info@pumabiotechnology.com
Investor Relations:
ir@pumabiotechnology.com
Follow Us:
|
